Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 Feb 15;330(Pt 1):389–396. doi: 10.1042/bj3300389

Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain.

M Van Wijnen 1, J G Stam 1, G T Chang 1, J C Meijers 1, P H Reitsma 1, R M Bertina 1, B N Bouma 1
PMCID: PMC1219152  PMID: 9461535

Abstract

Protein S is a vitamin K-dependent glycoprotein involved in the regulation of the anticoagulant activity of activated protein C (APC). Also, an anticoagulant role for protein S, independent of APC, has been described. Protein S has a unique C-terminal sex hormone binding globulin (SHBG)-like domain that represents about half of the molecule. To define the role of this domain in APC cofactor activity and in binding to C4b-binding protein (C4BP), we have constructed a recombinant protein S molecule of N-terminal residues 1-242 that lacks the SHBG domain (mini-protein S). A panel of monoclonal antibodies directed against the N-terminal region of protein S recognized plasma-derived protein S, wild-type recombinant protein S and mini-protein S with similar affinities, whereas a monoclonal antibody that recognizes an epitope in the SHBG domain did not detect mini-protein S. Mini-protein S did not bind to C4BP in a solid-phase binding assay, and the cofactor activity of mini-protein S was not inhibited by preincubation with C4BP. In a plasma coagulation assay, the cofactor activity of mini-protein S was lower than wild-type or plasma-derived preparations. In contrast, no difference in APC cofactor activities was observed when the preparations were tested in purified systems that monitor the APC-mediated degradation of factors Va or VIIIa. In conclusion, we constructed a protein S molecule that fails to bind C4BP and still displays cofactor activity for APC. This confirms the role of the C-terminal SHBG region in C4BP binding and demonstrates that N-terminal residues 1-242 are sufficient for the expression of APC cofactor activity in a system using purified components. In plasma, however, the C-terminal SHBG region plays a role in the expression of optimal APC cofactor activity.

Full Text

The Full Text of this article is available as a PDF (388.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bajaj S. P., Rapaport S. I., Prodanos C. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem. 1981;11(4):397–412. doi: 10.1080/00327488108065531. [DOI] [PubMed] [Google Scholar]
  2. Bakker H. M., Tans G., Janssen-Claessen T., Thomassen M. C., Hemker H. C., Griffin J. H., Rosing J. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem. 1992 Aug 15;208(1):171–178. doi: 10.1111/j.1432-1033.1992.tb17171.x. [DOI] [PubMed] [Google Scholar]
  3. Bangalore N., Drohan W. N., Orthner C. L. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands. Thromb Haemost. 1994 Sep;72(3):465–474. [PubMed] [Google Scholar]
  4. Bertina R. M., Ploos van Amstel H. K., van Wijngaarden A., Coenen J., Leemhuis M. P., Deutz-Terlouw P. P., van der Linden I. K., Reitsma P. H. Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood. 1990 Aug 1;76(3):538–548. [PubMed] [Google Scholar]
  5. Bertina R. M., van Wijngaarden A., Reinalda-Poot J., Poort S. R., Bom V. J. Determination of plasma protein S--the protein cofactor of activated protein C. Thromb Haemost. 1985 Apr 22;53(2):268–272. [PubMed] [Google Scholar]
  6. Bock P. E., Craig P. A., Olson S. T., Singh P. Isolation of human blood coagulation alpha-factor Xa by soybean trypsin inhibitor-sepharose chromatography and its active-site titration with fluorescein mono-p-guanidinobenzoate. Arch Biochem Biophys. 1989 Sep;273(2):375–388. doi: 10.1016/0003-9861(89)90496-7. [DOI] [PubMed] [Google Scholar]
  7. Borgel D., Gandrille S., Aiach M. Protein S deficiency. Thromb Haemost. 1997 Jul;78(1):351–356. [PubMed] [Google Scholar]
  8. Brunner J., Skrabal P., Hauser H. Single bilayer vesicles prepared without sonication. Physico-chemical properties. Biochim Biophys Acta. 1976 Dec 2;455(2):322–331. doi: 10.1016/0005-2736(76)90308-4. [DOI] [PubMed] [Google Scholar]
  9. Chang G. T., Maas B. H., Ploos van Amstel H. K., Reitsma P. H., Bertina R. M., Bouma B. N. Studies of the interaction between human protein S and human C4b-binding protein using deletion variants of recombinant human protein S. Thromb Haemost. 1994 Apr;71(4):461–467. [PubMed] [Google Scholar]
  10. Chang G. T., Ploos van Amstel H. K., Hessing M., Reitsma P. H., Bertina R. M., Bouma B. N. Expression and characterization of recombinant human protein S in heterologous cells--studies of the interaction of amino acid residues leu-608 to glu-612 with human C4b-binding protein. Thromb Haemost. 1992 May 4;67(5):526–532. [PubMed] [Google Scholar]
  11. Dahlbäck B., Hildebrand B., Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem. 1990 May 15;265(14):8127–8135. [PubMed] [Google Scholar]
  12. Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem. 1986 Sep 15;261(26):12022–12027. [PubMed] [Google Scholar]
  13. Di Scipio R. G., Hermodson M. A., Yates S. G., Davie E. W. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry. 1977 Feb 22;16(4):698–706. doi: 10.1021/bi00623a022. [DOI] [PubMed] [Google Scholar]
  14. DiScipio R. G., Davie E. W. Characterization of protein S, a gamma-carboxyglutamic acid containing protein from bovine and human plasma. Biochemistry. 1979 Mar 6;18(5):899–904. doi: 10.1021/bi00572a026. [DOI] [PubMed] [Google Scholar]
  15. Fernández J. A., Heeb M. J., Griffin J. H. Identification of residues 413-433 of plasma protein S as essential for binding to C4b-binding protein. J Biol Chem. 1993 Aug 5;268(22):16788–16794. [PubMed] [Google Scholar]
  16. Gershagen S., Fernlund P., Lundwall A. A cDNA coding for human sex hormone binding globulin. Homology to vitamin K-dependent protein S. FEBS Lett. 1987 Aug 10;220(1):129–135. doi: 10.1016/0014-5793(87)80890-6. [DOI] [PubMed] [Google Scholar]
  17. Grinnell B. W., Walls J. D., Marks C., Glasebrook A. L., Berg D. T., Yan S. B., Bang N. U. Gamma-carboxylated isoforms of recombinant human protein S with different biologic properties. Blood. 1990 Dec 15;76(12):2546–2554. [PubMed] [Google Scholar]
  18. Hackeng T. M., Hessing M., van 't Veer C., Meijer-Huizinga F., Meijers J. C., de Groot P. G., van Mourik J. A., Bouma B. N. Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C. J Biol Chem. 1993 Feb 25;268(6):3993–4000. [PubMed] [Google Scholar]
  19. Hackeng T. M., van 't Veer C., Meijers J. C., Bouma B. N. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem. 1994 Aug 19;269(33):21051–21058. [PubMed] [Google Scholar]
  20. He X., Shen L., Dahlbäck B. Expression and functional characterization of chimeras between human and bovine vitamin-K-dependent protein-S-defining modules important for the species specificity of the activated protein C cofactor activity. Eur J Biochem. 1995 Jan 15;227(1-2):433–440. doi: 10.1111/j.1432-1033.1995.tb20406.x. [DOI] [PubMed] [Google Scholar]
  21. Heeb M. J., Mesters R. M., Tans G., Rosing J., Griffin J. H. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem. 1993 Feb 5;268(4):2872–2877. [PubMed] [Google Scholar]
  22. Heeb M. J., Rosing J., Bakker H. M., Fernandez J. A., Tans G., Griffin J. H. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2728–2732. doi: 10.1073/pnas.91.7.2728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hessing M., Kanters D., Hackeng T. M., Bouma B. N. Identification of different forms of human C4b-binding protein lacking beta-chain and protein S binding ability. Thromb Haemost. 1990 Oct 22;64(2):245–250. [PubMed] [Google Scholar]
  24. Hessing M., Vlooswijk R. A., Hackeng T. M., Kanters D., Bouma B. N. The localization of heparin-binding fragments on human C4b-binding protein. J Immunol. 1990 Jan 1;144(1):204–208. [PubMed] [Google Scholar]
  25. Kalafatis M., Mann K. G. Role of the membrane in the inactivation of factor Va by activated protein C. J Biol Chem. 1993 Dec 25;268(36):27246–27257. [PubMed] [Google Scholar]
  26. Kane W. H., Majerus P. W. Purification and characterization of human coagulation factor V. J Biol Chem. 1981 Jan 25;256(2):1002–1007. [PubMed] [Google Scholar]
  27. Kisiel W. Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin. J Clin Invest. 1979 Sep;64(3):761–769. doi: 10.1172/JCI109521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Klein J. D., Walker F. J. Purification of a protein C activator from the venom of the southern copperhead snake (Agkistrodon contortrix contortrix). Biochemistry. 1986 Jul 29;25(15):4175–4179. doi: 10.1021/bi00363a001. [DOI] [PubMed] [Google Scholar]
  29. Koedam J. A., Meijers J. C., Sixma J. J., Bouma B. N. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest. 1988 Oct;82(4):1236–1243. doi: 10.1172/JCI113721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Koppelman S. J., Hackeng T. M., Sixma J. J., Bouma B. N. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII. Blood. 1995 Aug 1;86(3):1062–1071. [PubMed] [Google Scholar]
  31. Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488–492. doi: 10.1073/pnas.82.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kuwada M., Katayama K. An improved method for the determination of gamma-carboxyglutamic acid in proteins, bone, and urine. Anal Biochem. 1983 May;131(1):173–179. doi: 10.1016/0003-2697(83)90150-1. [DOI] [PubMed] [Google Scholar]
  33. Lu D., Kalafatis M., Mann K. G., Long G. L. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Blood. 1996 Jun 1;87(11):4708–4717. [PubMed] [Google Scholar]
  34. Malm J., Cohen E., Dackowski W., Dahlbäck B., Wydro R. Expression of completely gamma-carboxylated and beta-hydroxylated recombinant human vitamin-K-dependent protein S with full biological activity. Eur J Biochem. 1990 Feb 14;187(3):737–743. doi: 10.1111/j.1432-1033.1990.tb15361.x. [DOI] [PubMed] [Google Scholar]
  35. Meijers J. C., Davie E. W., Chung D. W. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood. 1992 Mar 15;79(6):1435–1440. [PubMed] [Google Scholar]
  36. Nelson R. M., Long G. L. Binding of protein S to C4b-binding protein. Mutagenesis of protein S. J Biol Chem. 1992 Apr 25;267(12):8140–8145. [PubMed] [Google Scholar]
  37. Nesheim M. E., Canfield W. M., Kisiel W., Mann K. G. Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C. J Biol Chem. 1982 Feb 10;257(3):1443–1447. [PubMed] [Google Scholar]
  38. Nesheim M. E., Myrmel K. H., Hibbard L., Mann K. G. Isolation and characterization of single chain bovine factor V. J Biol Chem. 1979 Jan 25;254(2):508–517. [PubMed] [Google Scholar]
  39. Perkins S. J., Chung L. P., Reid K. B. Unusual ultrastructure of complement-component-C4b-binding protein of human complement by synchrotron X-ray scattering and hydrodynamic analysis. Biochem J. 1986 Feb 1;233(3):799–807. doi: 10.1042/bj2330799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Regan L. M., Lamphear B. J., Huggins C. F., Walker F. J., Fay P. J. Factor IXa protects factor VIIIa from activated protein C. Factor IXa inhibits activated protein C-catalyzed cleavage of factor VIIIa at Arg562. J Biol Chem. 1994 Apr 1;269(13):9445–9452. [PubMed] [Google Scholar]
  41. Rosing J., Hoekema L., Nicolaes G. A., Thomassen M. C., Hemker H. C., Varadi K., Schwarz H. P., Tans G. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem. 1995 Nov 17;270(46):27852–27858. doi: 10.1074/jbc.270.46.27852. [DOI] [PubMed] [Google Scholar]
  42. Rouser G., Fkeischer S., Yamamoto A. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids. 1970 May;5(5):494–496. doi: 10.1007/BF02531316. [DOI] [PubMed] [Google Scholar]
  43. Shen L., Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem. 1994 Jul 22;269(29):18735–18738. [PubMed] [Google Scholar]
  44. Solymoss S., Tucker M. M., Tracy P. B. Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection. J Biol Chem. 1988 Oct 15;263(29):14884–14890. [PubMed] [Google Scholar]
  45. Váradi K., Rosing J., Tans G., Pabinger I., Keil B., Schwarz H. P. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation. Thromb Haemost. 1996 Aug;76(2):208–214. [PubMed] [Google Scholar]
  46. Walker F. J. Characterization of a synthetic peptide that inhibits the interaction between protein S and C4b-binding protein. J Biol Chem. 1989 Oct 25;264(30):17645–17648. [PubMed] [Google Scholar]
  47. Walker F. J. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem. 1981 Nov 10;256(21):11128–11131. [PubMed] [Google Scholar]
  48. van Wijnen M., Stam J. G., van't Veer C., Meijers J. C., Reitsma P. H., Bertina R. M., Bouma B. N. The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S. Thromb Haemost. 1996 Sep;76(3):397–403. [PubMed] [Google Scholar]
  49. van't Veer C., Hackeng T. M., Biesbroeck D., Sixma J. J., Bouma B. N. Increased prothrombin activation in protein S-deficient plasma under flow conditions on endothelial cell matrix: an independent anticoagulant function of protein S in plasma. Blood. 1995 Apr 1;85(7):1815–1821. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES